The Vadodara administration has begun analysing the effects of the drug Hydroxychloroquine (HCQ) in containing the cases in the city.
Category: RESEARCH
See the original Source: Rudy Giuliani Rudy Giuliani sits down with Dr. Vladimir Zelenko, MD, Board Certified in Family Medicine, to discuss the protocol he used to achieve a 99.7% survival rate for his COVID19 patients. Dr. Zelenko urges that America can continue to reopen and have maximum participation with the fallback of a very […]
Source: International Journal of Infectious Diseases Highlights As of May27, 2020 there are over 1,678,843 confirmed cases of COVID-19 claiming more than 100,000 lives in the Unites States. Currently there is no known effective therapy or vaccine. According to a protocol-based treatment algorithm, among hospitalized patients, use of hydroxychloroquine alone and in combination with azithromycin […]
In this study of over 6000 hospitalized patients with COVID-19 in the New York City, hydroxychloroquine use was associated with decreased mortality.
The UK medicines agency has given the green light to resume a clinical trial of hydroxychloroquine to prevent Covid-19.
Hydroxychloroquine use was associated with decreased mortality.
Source: Global Research by Dr. Meryl Nass It is remarkable that a series of events taking place over the past 3 months produced a unified message about hydroxychloroquine, and produced similar policies about the drug in the US, Canada, Australia, NZ and western Europe. The message is that generic, inexpensive hydroxychloroquine is dangerous and should not be […]
Our data suggest that chronic treatment with HCQ confer protection against SARS-CoV-2 infection.
No life-threatening modifications of the QT interval was observed in non-severe COVID-19 patients treated ambulatory with hydroxychloroquine and azithromycin. Studies are needed in critical-ill and older patients.
The clinical trials on this list are studying Hydroxychloroquine. All trials on the list are supported by NCI.
Origial Source: FranceSoir In the Recovery and Solidarity clinical trials, it is not excluded that patients died as a result of a therapeutic overdose of hydroxychloroquine. Hydroxychloroquine has not stopped being the subject of many conversations. 27 Brazilian researchers are now facing legal charges for a overdose that resulted in the deaths of 11 patients […]
Source: Science Direct Background In our institute in Marseille, France, we initiated early and massive screening for coronavirus disease 2019 (COVID-19). Hospitalization and early treatment with hydroxychloroquine and azithromycin (HCQ-AZ) was proposed for the positive cases. Methods We retrospectively report the clinical management of 3,737 screened patients, including 3,119 (83.5%) treated with HCQ-AZ (200 mg of […]
Source: BioRxiv The pandemic coronavirus COVID-19 affected global health from the end of 2019 to 2020 and may challenge global health in the future. There have been reports of Chloroquine (CQ) and Hydroxychloroquine (HCQ) used in clinical treatment. In our study, we used CCK-8 stain, flow cytometry and immunofluorescent stain to evaluated the toxicity and […]
This study provides evidence that (hydroxy)chloroquine may be used effectively in treating moderate COVID-19 and supports larger trials.
This represents a 25% relative increase in the likelihood of being discharged from hospital, the study said.
Conclusions: In subjects free of COVID-19, we found a small increase in QTc associated with use of chloroquine, but not hydroxychloroquine. We found no increased mortality associated with use of hydroxychloroquine.
This study provides evidence that (hydroxy)chloroquine may be used effectively in treating moderate COVID-19 and supports larger trials.
Source: Spectator Big Pharma laughs all the way to the bank. The Fawlty Towers episode ’Don’t Mention the War’ has been banned by the BBC but a new version of the comedy is playing in Britain’s Covid wards called ‘Don’t Mention the Hydroxychloroquine (HCQ).’ The clowns entertaining the injured in Britain’s battle with the coronavirus are Dr […]
It treats patients in the initial phase, if the patient is medicated at the very beginning of the symptoms, the disease may not reach the acute phase, where the use of respirators is necessary.
“As far as prophylaxis is concerned, more than 4,300 doctors and health works were given HCQ as approved by Indian Council of Medical Research (ICMR) out of which around 45 health persons tested positive and recovered later,”
Significantly higher rates of discharge home were observed in patients treated by HCQ, a novel finding warranting further confirmation in replicative studies.
How can we trust the established authorities or prestigious journals when, in this perilous time, trials of an available, inexpensive, long-established drug appear to be designed to fail, while risking the lives of their subjects through deliberate or negligent drug overdoses?
A Sungai Buloh Hospital clinician also described the controversial antimalarial drug, hydroxychloroquine, as an anchor during the peak of the Covid-19 crisis in Malaysia.
The hydroxychloroquine (HCQ) arm of the trials had been stopped after publication of the Lancet Surgisphere study, which claimed that patients who received hydroxychloroquine had 35% higher death rates, but the Lancet study was retracted 13 days after publication, as its data turned out to be fabricated.
It is not affected by the FDA’s decision today, and there is no evidence that the use of hydroxychloroquine as a potential prophylaxis presents a health risk in that setting.
The study, which was obviously flawed on its face (I commented well before it was exposed that the groupings made no sense), turned out to be produced by a shell company, with unverified data gathered by non-scientists.
India’s ICMR, its official medical research agency, had written to the WHO, telling WHO that the hydroxychloroquine doses being used in the Solidarity trial were 4 times higher than the doses being used in India.
None of the patients died in the studied period and only 6 have to be admitted in conventional hospitalization area.
Source: MedRxiv Abstract: The new SARS-CoV-2 infection named COVID-19 has severely hit our Health System. At the time of writing this paper no medical therapy is officially recommended or has shown results in improving the outcomes in COVID-19 patients. With the aim of diminishing the impact in Hospital admissions and reducing the number of medical […]
Source: MedRxiv Abstract Background: While several trials are ongoing for treatment of COVID-19, scientific research on chemoprophylaxis is still lacking even though it has potential to delay the pandemic allowing us time to complete research on vaccines. Methods: We have conducted a cohort study amongst Health Care Workers (HCW) exposed to COVID-19 patients, at a […]
Source: Jakarta Globe Researchers from Airlangga University, Government’s Covid-19 Task Force, and State Intelligence Agency (BIN) have claimed to have found combinations of medicine that effectively reduce the number of Sars-Cov-2, the coronavirus that causees Covid-19 disease, in the human body. The researchers have submitted the result to several scientific journals for peer review. “We have been conducting research on […]
Source: HVMN 13 days after publishing a paper on hydroxychloroquine (a potential drug for coronavirus treatment), The Lancet retracted the study due to faulty data. In the midst of a global pandemic, the study (that have since been retracted) was used as a basis for the guidelines set by the WHO, the CDC, elected officials, […]
Source: The Guardian Questions continue for Surgisphere and CEO Sapan Desai as universities deny knowledge of links to firm behind Lancet’s now-disputed blockbuster study. Dozens of scientific papers co-authored by the chief executive of the US tech company behind the Lancet hydroxychloroquine study scandal are now being audited, including onethat a scientific integrity expert claims contains images […]
Source: Pan American Health Organisation Importance: Patients in long-term care facilities (LTCF) are at a high-risk of contracting COVID-19 due to advanced age and multiple comorbidities. Without effective treatments, outbreaks in such facilities will become commonplace and will result in severe morbidity and mortality. The effectiveness of doxycycline (DOXY) and hydroxychloroquine (HCQ) combination therapy in […]
Source: Times of India Nagpur: Preventive measures taken by city police’s medical teams seemed to have worked better for them in comparison to their counterparts in Mumbai, Thane and Pune. Out of 423 city cops tested for Covid-19, only two constables — one from Tehsil police station and another posted at control room — have been found […]
Source: ScienceDirect | PDF of full Journal Pre-Print Abstract In the context of the current COVID-19 pandemic, we conducted a meta-analysis on the effects of chloroquine derivatives in patients, based on unpublished and published reports available publicly on the internet as of May, 27, 2020. The keywords “hydroxychloroquine”, “chloroquine”, “coronavirus”, “COVID-19” and “SARS-Cov-2” were used […]
Preface: On May 22, The Lancet published a study of 96,000 COVID-19 patients stating Hydroxychloroquine had no value in treating COVID-19 and even suggested increased risk of mortality. Literally dozens of studies around the globe, and significant evidence (in the thousands) that is still oddly being referred to as anecdotal, suggest strongly that HCQ has […]
On the 25th of May 2020, the World Health Organisation halted hyrdoxychloroquine trials globally within 72 hours of sighting a publication in the Lancet. They advised countries to do the same. The Lancet’s publication immediately came under severe scrutiny from the many of the world’s top doctors and universities of medicine, as well as various […]
Source: The Guardian The World Health Organization and a number of national governments have changed their Covid-19 policies and treatments on the basis of flawed data from a little-known US healthcare analytics company, also calling into question the integrity of key studies published in some of the world’s most prestigious medical journals. A Guardian investigation can reveal […]
Source: Indian Express In a statement, The Lancet said that “important scientific questions” were raised about data in the paper authored by cardiologist Mandeep Mehra, Desai and Zurich cardiologist Frank Ruschitzka. It said an independent audit has been commissioned. THE WORLD Health Organisation (WHO) has decided to resume the hydroxychloroquine (HCQ) part of its Solidarity Trial, a […]